MarketWatch

Landmark Bench Study Shows Dramatic Improvement in Ventricular Catheter Placement Accuracy with inTRAvent Medical's First in Class, FDA-Cleared SOLOPASS 2.0 Ultrasound-Guided ...

The MarketWatch News Department was not involved in the creation of this content. -- Peer-reviewed data published in Neurosurgery show that SOLOPASS(R) 2.0 delivers significantly higher accuracy than ...
Medical Xpress

Investigative Techniques: News and Research on Neuronavigation

A drug developed at The University of Texas Health Science Center at San Antonio (UT Health San Antonio) has been shown to extend survival for patients with glioblastoma, the most common primary brain ...
Morningstar

Landmark Bench Study Shows Dramatic Improvement in Ventricular Catheter Placement Accuracy with inTRAvent Medical’s First in Class, FDA-Cleared SOLOPASS 2.0 Ultrasound-Guided ...

98% of placements using SOLOPASS® 2.0 entered the ventricular system, versus only 10% of freehand placements. 86% of placements using SOLOPASS® 2.0 accurately reached the ipsilateral frontal horn ...